CIK 0001664710 · Non-accelerated filer<br>Smaller reporting company
Keros Therapeutics, Inc.
Sign in to watch- Ticker
- KROS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 811173868
- Phone
- 617-314-6297
- Business address
- 1050 WALTHAM STREET, SUITE 302, LEXINGTON, MA, 02421
- Open-market buys, last 90 days
- $10,270
- in 1 filing
- Open-market sales, last 90 days
- $101,136
- in 4 filings, $6K under 10b5-1 plans
Net −$90,866. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 78 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-07-13 | Lachey Jennifer Chief Scientific Officer | Option exercise | +1,916 | $0.30 | $575 | 93,184 |
| 2022-07-13 | Lachey Jennifer Chief Scientific Officer | Sale | −1,916 | $30.00 | $57K | 95,100 |
| 2022-07-13 | Lachey Jennifer Chief Scientific Officer | Option exercise · Employee Stock Option (right to buy) | −1,916 | 54,789 | ||
| 2022-06-14 | Lachey Jennifer Chief Scientific Officer | Option exercise | +9,400 | $0.30 | $3K | 95,100 |
| 2022-06-14 | Lachey Jennifer Chief Scientific Officer | Option exercise · Employee Stock Option (right to buy) | −9,400 | 56,705 | ||
| 2022-06-09 | Seehra Jasbir Chief Executive Officer | Option exercise | +5,000 | $0.30 | $2K | 248,856 |
| 2022-06-09 | Seehra Jasbir Chief Executive Officer | Option exercise · Employee Stock Option (right to buy) | −5,000 | 8,822 | ||
| 2022-06-01 | Nussbaum Ran Director | Grant or award · Stock Options (right to buy) | +8,293 | 8,293 | ||
| 2022-06-01 | Knowles Julius Director | Grant or award · Stock Options (right to buy) | +8,293 | 8,293 | ||
| 2022-06-01 | Kariv Tomer Director | Grant or award · Stock Options (right to buy) | +8,293 | 8,293 | ||
| 2022-06-01 | GRAY MARY ANN Director | Grant or award · Stock Options (right to buy) | +8,293 | 8,293 | ||
| 2022-06-01 | GORDON CARL L Director | Grant or award · Stock Options (right to buy) | +8,293 | 8,293 | ||
| 2020-04-13 | Knowles Julius Director | Purchase | +1,191 | $20.98 | $25K | 1,191 |
Page 9 of 9 · 173 trades